Tianjin TongRenTang Group Co., Ltd.   Report issue

For profit Phase 4
Founded: Tianjin China (1644)
Status: No NME R&D (1644)

Organization Overview

First Clinical Trial
2014
NCT02063100
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now